MSLN and ovarian carcinoma: As aforementioned, the interaction between MSLN and its unique known ligand MUC16 was suggested to play a key role during peritoneal dissemination, which is a step preceding hematogenic and lymphatic dissemination, in both ovarian cancers and PDAC [33,34].